WG2
Clinical management
๐ช๐๐ฎ (๐๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ ๐ฎ๐ป๐ฎ๐ด๐ฒ๐บ๐ฒ๐ป๐) is dedicated to the identification and selection of relevant but already existing PROMs for MS care. It verifies their state of employment and potential efficacy in existing attempts for introduction.ย
![Doctor writing papers Doctor writing papers](https://proms-initiative.org/wp-content/uploads/2022/12/collegamento-WG2.jpg)
Strategic objectives
- To identify current PROs and PROMs to be used in clinical care and collected in registries and advice relevant regulatory agencies and clinicians;
- Meet regulatory agencies position on PRO and PROMs (e.g. MSOAC EMA document);
- To promote, coordinate, implement and support initiatives aiming at validating and harmonizing PROs across cultures.
PROMS Initiative interview
Robert McBurney, Chief Research Officer of Accelerated Cure Project for Multiple Sclerosis (APC), a national non-profit organization dedicated to accelerating efforts toward a cure for MS by rapidly advancing research that determines its causes and mechanisms, is one of the co-leaders of the Clinical Management Working Group (WG2) of PROMS Initiative.
Recent activities
- Development of a Scoping Lit. Review on the โUse of Patient-Reported Outcomes in Multiple Sclerosis (MS) Clinical Managementโ.